Publicaciones (17) Publicaciones de MARTA RUIZ LÓPEZ

2024

  1. Understanding the olfactory role in post-COVID cognitive and neuropsychiatric manifestations

    Frontiers in Psychology, Vol. 15

2023

  1. Perampanel: Medical Alternative for Essential Tremor?

    Clinical Neuropharmacology, Vol. 46, Núm. 2, pp. 51-54

  2. Rapid Eye Movement Sleep Behavior Disorder in Parkinson's Disease: A Survey-Based Study

    Canadian Journal of Neurological Sciences, Vol. 50, Núm. 5, pp. 703-709

2022

  1. Pearls & Oy-sters: Challenges and Controversies in Wilson Disease

    Neurology, Vol. 99, Núm. 6, pp. 251-255

2021

  1. Self-adjustment of deep brain stimulation delays optimization in Parkinson's disease

    Brain Stimulation, Vol. 14, Núm. 3, pp. 676-681

2020

  1. Emergency room neurology in times of COVID-19: malignant ischaemic stroke and SARS-CoV-2 infection

    European Journal of Neurology

  2. Expanding Data Collection for the MDSGene Database: X-linked Dystonia-Parkinsonism as Use Case Example

    Movement Disorders, Vol. 35, Núm. 11, pp. 1933-1938

  3. Pandysautonomia and alpha-1 adrenergic receptor autoantibodies: a cause or a consequence? A case report

    Clinical Autonomic Research

  4. Status dystonicus induced by deep brain stimulation surgery

    Neurological Sciences

  5. Tratamiento farmacológico en tiempos de incertidumbre: uso de la hidroxicloroquina/cloroquina en el tratamiento de COVID-19

    Semergen: revista española de medicina de familia, Núm. 1, pp. 20-27

2019

  1. Diagnostic delay in Parkinson's disease caused by PRKN mutations

    Parkinsonism and Related Disorders, Vol. 63, pp. 217-220

  2. Patient-adjusted deep-brain stimulation programming is time saving in dystonia patients

    Journal of Neurology, Vol. 266, Núm. 10, pp. 2423-2429

  3. Seizures and movement disorders: Phenomenology, diagnostic challenges and therapeutic approaches

    Journal of Neurology, Neurosurgery and Psychiatry

2018

  1. ADCK3-related Coenzyme Q10 Deficiency: A Potentially Treatable Genetic Disease

    Movement Disorders Clinical Practice, Vol. 5, Núm. 6, pp. 635-639

  2. Letter in response to “Rethinking status dystonicus — A welcome start to a challenging problem”

    Movement Disorders

2017

  1. Rethinking status dystonicus

    Movement Disorders, Vol. 32, Núm. 12, pp. 1667-1676

2016

  1. Novel Levodopa Formulations for Parkinson’s Disease

    CNS Drugs, Vol. 30, Núm. 11, pp. 1079-1095